Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Matria Healthcare (MATR) -- Ignore unavailable to you. Want to Upgrade?

To: satish kamat who wrote (104)	2/4/1998 9:06:00 AM
From: GREATMOOD	Read Replies (2) \| Respond to of 220

satish, I am in agreement with your thinking. Matria is in the process of becoming a more diversified healthcare company in an industry with tremendous potential. They are constantly looking for ways to add top line revenues by building on their existing infrastructure. The approval of the Johnson & Johnson drug Antocin seems to be on track for becoming the safest FDA approved drug to inhibit labor, and the Matria Board will be meeting in February to discuss the implentation of a significant share buyback program. They have had excellent results marketing a software product for OB/GYN offices, and their Fertility business will be expanded. Their entry into the diabetes control market is doing very well, and this should boost revenues nicely. Earnings are due out towards the end of February, and they should be pretty much on target. I think the write-off for goodwill confuses investors because Matria will again report a loss even though they are profitable from ongoing operations. In the cycle of stock market Psychology, IMO, we are now just about leaving the "disillusion/capitulation" phase. I now sense that we are re-entering the "hope" phase because of the various catalysts now in place for future stock price appreciation. I'm looking forward to an "elation" phase later this year, and I wouldn't mind some "irrational exuberance" either. Have patience. I don't see any downside from here. The stock is dirt cheap, and the risk/reward ratio is excellent., GM